CD34 and acute myeloid leukemia: To further validate that primitive AML cells were very responsive to ouabain, CD34+ Kasumi-3 cells (early myeloblasts; M0) were treated with ouabain (0 − 300 nM), and apoptosis and subsequent LC50 were similarly evaluated at 48 h.